Wacker Chemie AG (WCH) - Net Assets
Based on the latest financial reports, Wacker Chemie AG (WCH) has net assets worth €3.76 Billion EUR (≈ $4.39 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€8.79 Billion ≈ $10.28 Billion USD) and total liabilities (€5.04 Billion ≈ $5.89 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore WCH current and non-current assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €3.76 Billion |
| % of Total Assets | 42.72% |
| Annual Growth Rate | 6.99% |
| 5-Year Change | 21.13% |
| 10-Year Change | 44.82% |
| Growth Volatility | 30.34 |
Wacker Chemie AG - Net Assets Trend (2004–2025)
This chart illustrates how Wacker Chemie AG's net assets have evolved over time, based on quarterly financial data. For live valuation and market cap data, see market value of Wacker Chemie AG.
Annual Net Assets for Wacker Chemie AG (2004–2025)
The table below shows the annual net assets of Wacker Chemie AG from 2004 to 2025. Explore Wacker Chemie AG operating cash flow efficiency to assess how effectively this company generates cash.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €3.76 Billion ≈ $4.39 Billion |
-22.36% |
| 2024-12-31 | €4.84 Billion ≈ $5.65 Billion |
+5.61% |
| 2023-12-31 | €4.58 Billion ≈ $5.35 Billion |
-8.96% |
| 2022-12-31 | €5.03 Billion ≈ $5.88 Billion |
+62.26% |
| 2021-12-31 | €3.10 Billion ≈ $3.62 Billion |
+83.26% |
| 2020-12-31 | €1.69 Billion ≈ $1.98 Billion |
-16.62% |
| 2019-12-31 | €2.03 Billion ≈ $2.37 Billion |
-35.50% |
| 2018-12-31 | €3.15 Billion ≈ $3.68 Billion |
-0.75% |
| 2017-12-31 | €3.17 Billion ≈ $3.71 Billion |
+22.22% |
| 2016-12-31 | €2.59 Billion ≈ $3.03 Billion |
-7.22% |
| 2015-12-31 | €2.80 Billion ≈ $3.27 Billion |
+43.60% |
| 2014-12-31 | €1.95 Billion ≈ $2.28 Billion |
-11.41% |
| 2013-12-31 | €2.20 Billion ≈ $2.57 Billion |
-16.07% |
| 2012-12-31 | €2.62 Billion ≈ $3.06 Billion |
-0.45% |
| 2011-12-31 | €2.63 Billion ≈ $3.07 Billion |
+7.48% |
| 2010-12-31 | €2.45 Billion ≈ $2.86 Billion |
+25.97% |
| 2009-12-31 | €1.94 Billion ≈ $2.27 Billion |
-6.74% |
| 2008-12-31 | €2.08 Billion ≈ $2.44 Billion |
+12.57% |
| 2007-12-31 | €1.85 Billion ≈ $2.16 Billion |
+17.86% |
| 2006-12-31 | €1.57 Billion ≈ $1.84 Billion |
+68.61% |
| 2005-12-31 | €931.10 Million ≈ $1.09 Billion |
+2.41% |
| 2004-12-31 | €909.20 Million ≈ $1.06 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Wacker Chemie AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 19473.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €3.15 Billion | 87.55% |
| Common Stock | €260.80 Million | 7.25% |
| Other Comprehensive Income | €74.20 Million | 2.06% |
| Other Components | €113.10 Million | 3.14% |
| Total Equity | €3.60 Billion | 100.00% |
Wacker Chemie AG Competitors by Market Cap
The table below lists competitors of Wacker Chemie AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dianthus Therapeutics Inc.
NASDAQ:DNTH
|
$4.63 Billion |
|
Choice Hotels International Inc
NYSE:CHH
|
$4.63 Billion |
|
Dottikon Es Holding AG
SW:DESN
|
$4.63 Billion |
|
Indofood Cbp Sukses Makmur Tbk
JK:ICBP
|
$4.63 Billion |
|
CCOOP Group Co Ltd
SHE:000564
|
$4.62 Billion |
|
Budimex S.A.
WAR:BDX
|
$4.62 Billion |
|
Alkermes Plc
NASDAQ:ALKS
|
$4.62 Billion |
|
Merdeka Copper Gold PT
JK:MDKA
|
$4.62 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wacker Chemie AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,669,200,000 to 3,599,400,000, a change of -1,069,800,000 (-22.9%).
- Net loss of 821,100,000 reduced equity.
- Dividend payments of 124,200,000 reduced retained earnings.
- Other comprehensive income decreased equity by 124,200,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-821.10 Million | -22.81% |
| Dividends Paid | €124.20 Million | -3.45% |
| Other Comprehensive Income | €-124.20 Million | -3.45% |
| Other Changes | €-300.00K | -0.01% |
| Total Change | €- | -22.91% |
Book Value vs Market Value Analysis
This analysis compares Wacker Chemie AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.29x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.37x to 1.29x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | €17.43 | €93.65 | x |
| 2005-12-31 | €21.00 | €93.65 | x |
| 2006-12-31 | €31.60 | €93.65 | x |
| 2007-12-31 | €37.25 | €93.65 | x |
| 2008-12-31 | €41.35 | €93.65 | x |
| 2009-12-31 | €38.76 | €93.65 | x |
| 2010-12-31 | €48.76 | €93.65 | x |
| 2011-12-31 | €52.41 | €93.65 | x |
| 2012-12-31 | €52.33 | €93.65 | x |
| 2013-12-31 | €43.86 | €93.65 | x |
| 2014-12-31 | €38.70 | €93.65 | x |
| 2015-12-31 | €51.70 | €93.65 | x |
| 2016-12-31 | €47.90 | €93.65 | x |
| 2017-12-31 | €62.79 | €93.65 | x |
| 2018-12-31 | €62.14 | €93.65 | x |
| 2019-12-31 | €39.59 | €93.65 | x |
| 2020-12-31 | €32.71 | €93.65 | x |
| 2021-12-31 | €60.76 | €93.65 | x |
| 2022-12-31 | €97.91 | €93.65 | x |
| 2023-12-31 | €88.91 | €93.65 | x |
| 2024-12-31 | €93.99 | €93.65 | x |
| 2025-12-31 | €72.45 | €93.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wacker Chemie AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -22.81%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -14.97%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 2.44x
- Recent ROE (-22.81%) is below the historical average (8.18%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 1.77% | 0.64% | 0.89x | 3.10x | €-74.82 Million |
| 2005 | 15.43% | 5.21% | 0.94x | 3.14x | €50.59 Million |
| 2006 | 19.83% | 9.33% | 1.02x | 2.08x | €154.31 Million |
| 2007 | 22.81% | 11.16% | 0.97x | 2.12x | €236.97 Million |
| 2008 | 21.34% | 10.20% | 0.93x | 2.25x | €232.90 Million |
| 2009 | -3.87% | -2.00% | 0.82x | 2.36x | €-267.05 Million |
| 2010 | 20.52% | 10.47% | 0.86x | 2.27x | €254.79 Million |
| 2011 | 13.68% | 7.25% | 0.79x | 2.40x | €95.76 Million |
| 2012 | 4.34% | 2.43% | 0.73x | 2.43x | €-147.16 Million |
| 2013 | 0.12% | 0.06% | 0.71x | 2.91x | €-215.28 Million |
| 2014 | 10.60% | 4.22% | 0.69x | 3.61x | €11.56 Million |
| 2015 | 9.61% | 4.66% | 0.73x | 2.83x | €-10.12 Million |
| 2016 | 7.53% | 3.87% | 0.62x | 3.14x | €-58.74 Million |
| 2017 | 7.44% | 4.71% | 0.72x | 2.19x | €-79.92 Million |
| 2018 | 7.97% | 4.94% | 0.70x | 2.31x | €-62.62 Million |
| 2019 | -32.67% | -13.04% | 0.76x | 3.30x | €-839.29 Million |
| 2020 | 11.64% | 4.03% | 0.68x | 4.28x | €26.68 Million |
| 2021 | 26.73% | 13.00% | 0.76x | 2.69x | €505.05 Million |
| 2022 | 25.72% | 15.24% | 0.87x | 1.93x | €764.62 Million |
| 2023 | 7.10% | 4.90% | 0.72x | 2.00x | €-128.08 Million |
| 2024 | 5.16% | 4.21% | 0.61x | 2.02x | €-225.92 Million |
| 2025 | -22.81% | -14.97% | 0.62x | 2.44x | €-1.18 Billion |
Industry Comparison
This section compares Wacker Chemie AG's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $3,039,854,957
- Average return on equity (ROE) among peers: -28.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wacker Chemie AG (WCH) | €3.76 Billion | 1.77% | 1.34x | $4.63 Billion |
| GRAPHENE MANUFACT.GROUP (0GF) | $8.54 Million | -86.66% | 0.78x | $152.93 Million |
| Orion Engineered Carbons SA (0OE) | $474.90 Million | 9.31% | 2.91x | $318.41 Million |
| H&R GmbH & Co. KGaA (2HRA) | $471.16 Million | 9.06% | 1.04x | $183.88 Million |
| Dotz Nano Ltd (57N) | $421.99K | -248.22% | 1.80x | $3.81 Million |
| EXPLOS. PROD. CHIM.EO 31 (9Z50) | $144.93 Million | 14.73% | 2.07x | $536.15 Million |
| Altech Chemicals Ltd (A3Y) | $88.93 Million | 2.62% | 0.01x | $27.76 Million |
| AlzChem Group AG (ACT) | $68.66 Million | 28.68% | 4.16x | $1.83 Billion |
| AIR LIQUIDE ADR 1/5/EO 11 (AILA) | $24.57 Billion | 11.23% | 1.02x | $103.86 Billion |
| AKZO NOBEL SPONS.ADRS 1/3 (AKUP) | $4.55 Billion | 9.72% | 2.20x | $8.57 Billion |
| BRAIN Biotech AG (BNN) | $23.01 Million | -35.97% | 2.08x | $51.56 Million |
About Wacker Chemie AG
Wacker Chemie AG, together with its subsidiaries, produces and sells chemical products in Europe, Asia, the Americas, and internationally. The company operates through four segments: Silicones, Polymers, Biosolutions, and Polysilicon. It offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silica; and binders and polymeric additives, … Read more